We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+7.06%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.9B
AUM Growth
+$1.75B
(+7.2%)
Cap. Flow
+$434M
Cap. Flow
% of AUM
1.67%
Top 10 Holdings %
Top 10 Hldgs %
23.48%
Holding
1,080
New
134
Increased
325
Reduced
445
Closed
139
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$189M |
| 2 |
Intel
INTC
|
+$180M |
| 3 |
Amphenol
APH
|
+$132M |
| 4 |
Intuit
INTU
|
+$106M |
| 5 |
Southwest Airlines
LUV
|
+$86.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$221M |
| 2 |
Constellation Energy
CEG
|
+$181M |
| 3 |
Uber
UBER
|
+$169M |
| 4 |
Mastercard
MA
|
+$140M |
| 5 |
Exelon
EXC
|
+$108M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.39% |
| 2 | Financials | 14.25% |
| 3 | Consumer Discretionary | 12.97% |
| 4 | Industrials | 12.61% |
| 5 | Healthcare | 10.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
StoneX
SNEX
$8.99B
| $7.53M | 0.03% |
310,503
-283,720
| -48% | -$6.69M |
|
377
Xperi
XPER
$368M
| $7.42M | 0.03% |
802,736
+5,047
| +0.6% | +$41.5K |
|
|
CCRN
378
DELISTED
Cross Country Healthcare
CCRN
| $7.35M | 0.03% |
+546,909
| New | +$8.06M |
|
379
CVS Health
CVS
$140B
| $7.23M | 0.03% |
+115,032
| New | +$6.71M |
|
380
Costco
COST
$429B
| $7.2M | 0.03% |
+8,125
| New | +$7.05M |
|
381
Stepan Co
SCL
$1.32B
| $7.11M | 0.03% |
92,053
+73,976
| +409% | +$5.86M |
|
|
SHYF
382
DELISTED
The Shyft Group
SHYF
| $7.08M | 0.03% |
564,242
+78,550
| +16% | +$1.01M |
|
383
Kelly Services Class A
KELYA
$560M
| $7.06M | 0.03% |
329,932
+56,457
| +21% | +$1.2M |
|
384
Moelis & Co
MC
$5.1B
| $6.97M | 0.03% |
+101,741
| New | +$6.57M |
|
385
Apogee Enterprises
APOG
$873M
| $6.92M | 0.03% |
98,810
-17,257
| -15% | -$1.11M |
|
386
Astec Industries
ASTE
$1.26B
| $6.89M | 0.03% |
215,654
+41,130
| +24% | +$1.32M |
|
387
Heartland Express
HTLD
$1.04B
| $6.86M | 0.03% |
559,031
-4,006
| -0.7% | -$49.2K |
|
|
DESP
388
DELISTED
Despegar.com
DESP
| $6.76M | 0.03% |
+545,554
| New | +$6.56M |
|
389
Vanda Pharmaceuticals
VNDA
$310M
| $6.71M | 0.03% |
1,430,533
-55,729
| -4% | -$299K |
|
390
Ardagh Metal Packaging
AMBP
$3.11B
| $6.7M | 0.03% |
1,778,166
+489,146
| +38% | +$1.73M |
|
|
ACLX
391
DELISTED
Arcellx
ACLX
| $6.68M | 0.03% |
79,936
+32,119
| +67% | +$2.14M |
|
392
SunCoke Energy
SXC
$779M
| $6.57M | 0.03% |
757,266
-78,376
| -9% | -$726K |
|
393
Zymeworks
ZYME
$1.66B
| $6.56M | 0.03% |
522,640
-129,088
| -20% | -$1.41M |
|
|
SLRN
394
DELISTED
ACELYRIN
SLRN
| $6.54M | 0.03% |
1,326,391
-153,465
| -10% | -$792K |
|
|
PLGO
395
Pelagos Insurance Capital
PLGO
$2.22B
| $6.53M | 0.03% |
361,485
-10,478
| -3% | -$185K |
|
396
DaVita
DVA
$15.4B
| $6.46M | 0.02% |
39,418
-16,339
| -29% | -$2.41M |
|
|
ETWO
397
DELISTED
E2open Parent Holdings
ETWO
| $6.36M | 0.02% |
+1,442,108
| New | +$6.31M |
|
398
RingCentral
RNG
$4.77B
| $6.36M | 0.02% |
201,029
+4,332
| +2% | +$137K |
|
399
Argan
AGX
$7.33B
| $6.35M | 0.02% |
62,567
-36,041
| -37% | -$2.85M |
|
400
Barrett Business Services
BBSI
$1.01B
| $6.34M | 0.02% |
169,146
-87,994
| -34% | -$3.1M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2024 Portfolio in Review
As of Q3 2024, Jacobs Levy Equity Management held 1,080 positions worth $25.9B, up 7.2% from $24.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jacobs Levy Equity Management's Q3 2024 filing shows 134 new, 325 increased, 445 reduced and 139 closed positions. Its largest new stake was Lam Research: 962,880 shares worth $78.6M. The largest sale was Fortinet, an estimated $221M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q3 2024 buy was Lam Research: 962,880 shares worth $78.6M.
- Jacobs Levy Equity Management added most to Edwards Lifesciences in Q3 2024, an estimated $189M increase.
- Jacobs Levy Equity Management's biggest Q3 2024 reduction was Fortinet, cutting an estimated $221M.
- Jacobs Levy Equity Management fully exited Smartsheet Inc. in Q3 2024, selling an estimated $81.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 23% of its $25.9B portfolio in Q3 2024.
- Jacobs Levy Equity Management opened 134 new positions and closed 139 in Q3 2024.
- Jacobs Levy Equity Management's portfolio value rose 7.2% quarter-over-quarter to $25.9B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2024, filed 14 Nov 2024.